ArticleAntimicrobial agents and chemotherapy2002
Propranolol inhibits hyphal development in Candida albicans.
Article in Antimicrobial agents and chemotherapy, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 21 citations in OpenAlex.
- Propranolol is efficacious againstAntimicrobial agents and chemotherapy · 2025Article
- Identification of propranolol and derivatives that are chemical inhibitors of phosphatidate phosphatase as potential broad-spectrum fungicides.Plant communications · 2024Article
- Propranolol Ameliorates the Antifungal Activity of Azoles in Invasive Candidiasis.Pharmaceutics · 2023Article
- Impeding Virulence of Candida albicans by Candesartan and Domperidone.Current microbiology · 2021Article
- Drugs with new lease of life as quorum sensing inhibitors: for combating MDR Acinetobacter baumannii infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020Article
- Natamycin and Voriconazole Exhibit Synergistic Interactions with Nonantifungal Ophthalmic Agents againstAntimicrobial agents and chemotherapy · 2019Article
- Modulation of morphogenesis in Candida albicans by various small molecules.Eukaryotic cell · 2011Review
- Role of actin cytoskeletal dynamics in activation of the cyclic AMP pathway and HWP1 gene expression in Candida albicans.Eukaryotic cell · 2007Article
- Cellular and molecular biology of Candida albicans estrogen response.Eukaryotic cell · 2006Article
- Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women.Drug safety · 2005Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Propranolol was used to investigate the role of phosphatidic acid (PA) and diacylglycerol in the dimorphic transition in Candida albicans. Propranolol was able to inhibit the appearance of germ tubes without decreasing growth rate. Data suggest that inhibition of morphogenesis may be due to binding by propranolol of PA derived from PLD1 hydrolysis of phosphatidylcholine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.